NINDS Human Genetics Resource Center

National Institute of Neurological Disorders and Stroke


The National Institute of Neurological Disorders and Stroke is committed to gene discovery, as a strategy for identifying the genetic causes and correlates of nervous system disorders. The NINDS Human Genetics Resource Center banks samples from subjects with cerebrovascular disease, dystonia, epilepsy, motor neuron disease, Parkinsonism and Tourette Syndrome, as well as population controls. 

Available samples 

Cerebrovascular Disease  DNA  LCL 
Dystonia  DNA  LCL 
Epilepsy  DNA  LCL 
Motor Neuron Disease DNA  LCL 
Parkinsonism  DNA  LCL 
Tourette Syndrome  DNA  LCL 
Controls  DNA  LCL 


New Cerebrovascular Disease Samples Available!

More than 1000 African American DNA samples from the REasons for Geographic and Racial Differences in Stroke (REGARDS) project  have been added to the NINDS Human Genetics Resource Center and are available through the catalog to the scientific community. Since 2003, REGARDS, a NINDS funded project, has worked to better understand geographic and ethnic contributions to risk of stroke.


  • Dec 2018

    Comprehensive genotyping of the C9orf72 hexanucleotide repeat region in 2095 ALS samples from the NINDS collection using a two-mode, longread PCR assay

    This study, using a novel bimodal PCR assay capable of amplifying nearly 100% of GC-rich sequences, provides comprehensive genotyping of the C9orf72 repeat region for over 2000 ALS samples collected in the National Institute of Neurological Disorders and Stroke (NINDS) Human Genetics Resource Center.

    read more

  • Jul 2018

    Regional Collapsing of Rare Variation Implicates Specific Genic Regions in ALS

    This study, published in bioRxiv, developed two collapsing strategies. The new analyses not only pinpoint risk regions in known genes but also highlight candidate genes as well.

    read more

  • May 2018

    Identification of novel circulatory microRNA signatures linked to patients with ischemic stroke

    MiRNAs identified in this study could potentially be used as disease biomarkers and for the development of novel therapeutic approaches.

    read more
Other News